| Original language | English (US) |
|---|---|
| Pages (from-to) | 389-390 |
| Number of pages | 2 |
| Journal | Clinical Infectious Diseases |
| Volume | 64 |
| Issue number | 3 |
| DOIs | |
| State | Published - Feb 1 2017 |
Bibliographical note
Funding Information:grants from the National Institutes of Health during the conduct of the study and is supported by Lundbeckfonden (grant number R219-2016– 762). A. B. reports grants from the University of Minnesota and the UK Medical Research Council during the conduct of the study. T. W. reports grants from Bristol Myers-Squibb and Gilead Sciences, and grants and personal fees from GlaxoSmithKline/ViiV during the conduct of the study. All other authors report no potential conflicts. The authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. The present study was supported by the Research Council at Rigshospitalet and by the Danish National Research Foundation (grant DNRF126).